(Q36717718)

15 August 2017

GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol (English)

1 reference

15 August 2017

8

1 reference

15 August 2017

10

1 reference

15 August 2017

11

1 reference

15 August 2017

David Nutt

7

0 references

Deborah J Sharp

object named as

Deborah Sharp

9

0 references

Philip Cowen

object named as

Philip Cowen

6

0 references

Nicola J Wiles

object named as

Nicola Wiles

5

0 references

author name string

Laura Thomas

1

1 reference

15 August 2017

Jean Mulligan

2

1 reference

15 August 2017

Victoria Mason

3

1 reference

15 August 2017

Debbie Tallon

4

1 reference

15 August 2017

22 May 2008

1 reference

15 August 2017

1 reference

15 August 2017

9

1 reference

15 August 2017

1

1 reference

17 June 2019

page(s)

29

1 reference

https://scigraph.springernature.com/pub.10.1186/1745-6215-9-29

15 August 2017

0 references

cites work

An Inventory for Measuring Depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Lost human capital from early-onset chronic depression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Polymorphism in serotonin transporter gene associated with susceptibility to major depression.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

The global burden of disease in 1990: summary results, sensitivity analysis and future directions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

The hospital anxiety and depression scale

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Intravenous versus oral treatment of endogenously depressed patients with doxepin--a double-blind study with plasma level determination

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

On power and sample size for studying features of the relative odds of disease

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers

28 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

28 June 2018

https://api.crossref.org/works/10.1186%2F1745-6215-9-29

Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2426669

Bipolar disorder and the serotonin transporter gene: a family-based association study

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1745-6215-9-29

Serotonin transporter gene polymorphism and antidepressant response

21 January 2018

1 reference

12 December 2020

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

12 December 2020

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine

1 reference

12 December 2020

1 reference

12 December 2020

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

12 December 2020

Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs: Meta-regression analysis

1 reference

12 December 2020

Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder

1 reference

12 December 2020

The impact of antidepressant use on social functioning: reboxetine versus fluoxetine

1 reference

12 December 2020

Identifiers

DOI

10.1186/1745-6215-9-29

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference